DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/strjbk/global_hemophilia) has announced the addition of the "Global Hemophilia Pipeline Highlights - 2014" report to their offering.
The latest report "Hemophilia Pipeline Highlights - 2014", provides most up-to-date information on key pipeline molecules in the global hemophilia market. It covers emerging therapies for hemophilia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
-
The report provides hemophilia pipeline molecules by clinical trial
stages including both early and late stage development - phase 3
clinical trials, phase 2 clinical trials, phase 1 clinical trials,
preclinical research, and discovery stage.
Drug Mechanism Classes:
-
The report provides hemophilia pipeline molecules by their dominant
mechanism of action. This helps executives categorize molecules based
on their drug class and also assess the strengths and weaknesses of
compounds.
Company:
-
The report provides hemophilia pipeline molecules by the Originator
Company.
Short-term Launch Highlights:
- Find out which hemophilia pipeline products will be launched in the US and Ex-US till 2017.
SUMMARY:
- Hemophilia phase 3 clinical trial pipeline molecules
- Hemophilia phase 2 clinical trial pipeline molecules
- Hemophilia phase 1 clinical trial pipeline molecules
- Hemophilia preclinical research pipeline molecules
- Hemophilia discovery stage pipeline molecules
-
Hemophilia pipeline molecules short-term launch highlights
Key Topics Covered:
1. Hemophilia Pipeline by Stages
2. Hemophilia Pipeline by Drug Class
3. Hemophilia Pipeline by Company
4. Hemophilia Phase 3 Clinical Trial Insights
5. Hemophilia Phase 2 Clinical Trial Insights
6. Hemophilia Phase 1 Clinical Trial Insights
7. Hemophilia Preclinical Research Insights
8. Hemophilia Discovery Stage Insights
9. Appendix
10. Research Methodology
For more information visit http://www.researchandmarkets.com/research/strjbk/global_hemophilia
